Company Info

Number of Employees

1260

Revenue

$126.6

Visit Website

Hovione

CDMO, Pharma Intermediates

Tagline

In it for Life

Overview

Hovione is an international CDMO with over 57 years of experience developing and manufacturing APIs and intermediates. Headquartered in Portugal, Hovione has four FDA inspected sites in the US, China and Europe. Hovione specializes in the development and manufacture of innovative drugs, including highly potent compounds, as well as generic API products for companies seeking to market off-patent drugs. A leading provider of commercial spray drying services, Hovione has over 12 years of experience in particle engineering process development and scale-up. Hovione offers proprietary product development and licensing opportunities for drug products and general analytical, supply, quality and compliance support.

Company Services

Services/CapabilitiesCDMO

+ Development Services

Analytical Development & Validation
Preformulation/Formulation
Process Development & Validation
Scale Up/Tech Transfer
Stability Testing

+ Drug Product Manufacturing

Cytotoxic / High Potency Compounds (OEL < 1µg/m3)

+ Drug Substance Manufacturing

Advanced Intermediates

Services/CapabilitiesPharma Intermediates

Contributions

Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program

Jean-Luc Herbeaux to Become Hovione CEO

Hovione and Zerion Pharma Announce a Strategic Partnership to Market the Dispersome® Technology Platform

Hovione and iBET Announce Strategic Collaboration

Hovione Completes its Phase II Clinical Trial of the First Minocycline Ophthalmic Showing Promise in Dry Eye Disease Associated with Inflamed Meibomian Gland Dysfunction